LLIT vs. AEMD, RSLS, DYNT, GMVDF, IONM, QNRX, BJDX, INVO, NMRD, and SINT
Should you be buying Lianluo Smart stock or one of its competitors? The main competitors of Lianluo Smart include Aethlon Medical (AEMD), ReShape Lifesciences (RSLS), Dynatronics (DYNT), G Medical Innovations (GMVDF), Assure (IONM), Quoin Pharmaceuticals (QNRX), Bluejay Diagnostics (BJDX), INVO Bioscience (INVO), Nemaura Medical (NMRD), and Sintx Technologies (SINT). These companies are all part of the "medical" sector.
Aethlon Medical (NASDAQ:AEMD) and Lianluo Smart (NASDAQ:LLIT) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, community ranking, analyst recommendations, risk, dividends, media sentiment and valuation.
Aethlon Medical received 112 more outperform votes than Lianluo Smart when rated by MarketBeat users. However, 70.27% of users gave Lianluo Smart an outperform vote while only 54.27% of users gave Aethlon Medical an outperform vote.
2.0% of Aethlon Medical shares are owned by institutional investors. Comparatively, 28.8% of Lianluo Smart shares are owned by institutional investors. 4.0% of Aethlon Medical shares are owned by insiders. Comparatively, 22.9% of Lianluo Smart shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Aethlon Medical has a beta of 1.95, indicating that its share price is 95% more volatile than the S&P 500. Comparatively, Lianluo Smart has a beta of 0.16, indicating that its share price is 84% less volatile than the S&P 500.
Aethlon Medical's return on equity of 0.00% beat Lianluo Smart's return on equity.
Lianluo Smart has lower revenue, but higher earnings than Aethlon Medical.
In the previous week, Aethlon Medical had 3 more articles in the media than Lianluo Smart. MarketBeat recorded 8 mentions for Aethlon Medical and 5 mentions for Lianluo Smart. Lianluo Smart's average media sentiment score of 0.07 beat Aethlon Medical's score of 0.00 indicating that Aethlon Medical is being referred to more favorably in the media.
Aethlon Medical presently has a consensus price target of $10.00, suggesting a potential upside of 2,393.77%. Given Lianluo Smart's higher possible upside, analysts clearly believe Aethlon Medical is more favorable than Lianluo Smart.
Summary
Aethlon Medical and Lianluo Smart tied by winning 7 of the 14 factors compared between the two stocks.
Get Lianluo Smart News Delivered to You Automatically
Sign up to receive the latest news and ratings for LLIT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding LLIT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Lianluo Smart Competitors List
Related Companies and Tools
